Finally, we cannot exclude the possibility that other reasons (e.g., different stability of mutant RAD51 proteins or mRNA, different sensitivity of tumours to detection by the immune system, and many other possibilities...) that are not yet identified or characterized might also participate in the RAD51 paradox. The gene discussed is RAD51; the disease is neoplasm.